Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid

By LabMedica International staff writers
Posted on 13 Aug 2025

Vaginal health depends on maintaining a balanced microbiome, particularly certain Lactobacillus species. More...

Disruption of this balance, known as dysbiosis, can increase risks of infection, pregnancy complications, and other long-term health issues. Existing diagnostic methods often fail to detect Lactobacillus iners, a key protective bacterium, or identify early microbiome changes. Now, a new optical approach offers a faster, noninvasive way to spot microbial imbalances.

Researchers at Vanderbilt University (Nashville, TN, USA) tested surface-enhanced Raman spectroscopy (SERS), a technique that captures biochemical fingerprints from vaginal fluid. In a pilot study, they collected samples from 19 participants during routine exams and analyzed them using both a laboratory Raman microscope and a portable Raman spectrometer. The SERS spectra revealed proteins, lipids, organic acids, and sugars. The team then used a separate molecular technique, quantitative PCR, to identify key microbes in each sample.

The study, published in Biophotonics Discovery, compared spectral profiles to molecular results from quantitative PCR. Gardnerella vaginalis, linked to bacterial vaginosis, produced elevated protein and lipid signals with reduced organic acids. Lactobacillus iners showed higher organic acid levels and fewer protein and polysaccharide signals. These trends matched known microbial effects on the vaginal environment and were visible with both lab and portable systems.

Notably, G. vaginalis signatures were found in samples from participants without symptoms or diagnosed infections, suggesting the method can detect early or subclinical microbiome shifts. The portable Raman spectrometer produced results comparable to benchtop systems, showing the technology’s potential for point-of-care use without a full lab setup.

This approach could support routine vaginal health monitoring and earlier intervention for microbiome imbalances. While the pilot study assessed only a few bacterial species, future research will expand the participant pool and employ genetic sequencing for broader microbial coverage. The findings lay the groundwork for less subjective, more accessible diagnostics in women’s health.

Related Links:
Vanderbilt University


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.